Jardiance Lowers Risk of Cardiovascular Death, But Price is Three Times Higher in U.S. than Abroad
Image by Svilen.milev
As reported today in The New York Times, a new study shows that the diabetes drug Jardiance (empagliflozin) can reduce the risk of dying from cardiovascular disease by 38%. The drug not only reduces blood sugar levels, but also blood pressure and arterial stiffness leading to a reduced risk of heart failure.
The cost of Jardiance in the U.S. is about $350 to $400 for just 30 pills. It would be a shame if people could not get this medication due to its high cost. Fortunately, this drug is available from licensed pharmacies in other countries (where the price is controlled or negotiated) at prices which are about 70% lower than in the U.S. As shown on PharmacyChecker.com, the 10 mg dose is available from several verified international online pharmacies for about $110 a month or, better, if purchasing a 3 month supply, it’s under $300. The 25 mg dose is only a few dollars more.
